Angelo Raggioli
Head
ItalyResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Angelo Raggioli is the Head at Reithera in Italy. His research focuses on the development of viral vector-based vaccines, with recent articles examining the immunogenicity and safety of adenoviral candidates, particularly those derived from gorillas and chimpanzees, in response to COVID-19. His work contributes significantly to the field of vaccine development and optimization.
Articles (3)
Year:
2022
Year:
2022
Year:
2021
Collaborators (5)
Markus Maeurer
University of Mainz
Francesco Talotta
Institute of Genetic and Molecular and Cellular Biology
Richard Urbanowicz
Lecturer in Infection Immunology
University of Liverpool
Daniela Benati
University of Modena and Reggio Emilia
Stefania Capone
head of preclinical and clinical immunology
AKERN Srl
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.